173 related articles for article (PubMed ID: 21852044)
41. Usability and effectiveness of Suprathel
Rashaan ZM; Krijnen P; Allema JH; Vloemans AF; Schipper IB; Breederveld RS
Eur J Trauma Emerg Surg; 2017 Aug; 43(4):549-556. PubMed ID: 27432172
[TBL] [Abstract][Full Text] [Related]
42. Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns.
Gerding RL; Imbembo AL; Fratianne RB
J Trauma; 1988 Aug; 28(8):1265-9. PubMed ID: 3411648
[TBL] [Abstract][Full Text] [Related]
43. Suprathel(®) causes less bleeding and scarring than Mepilex(®) Transfer in the treatment of donor sites of split-thickness skin grafts.
Kaartinen IS; Kuokkanen HO
J Plast Surg Hand Surg; 2011 Sep; 45(4-5):200-3. PubMed ID: 22150140
[TBL] [Abstract][Full Text] [Related]
44. Biobrane: a versatile tool in the armamentarium of the reconstructive and burns surgeon.
Whitaker IS; Mallinson P; Drew PJ
Plast Reconstr Surg; 2008 Mar; 121(3):152e-153e. PubMed ID: 18317116
[No Abstract] [Full Text] [Related]
45. Outpatient management of partial-thickness burns: Biobrane versus 1% silver sulfadiazine.
Gerding RL; Emerman CL; Effron D; Lukens T; Imbembo AL; Fratianne RB
Ann Emerg Med; 1990 Feb; 19(2):121-4. PubMed ID: 2405749
[TBL] [Abstract][Full Text] [Related]
46. The optimal timing of outpatient Biobrane™ application for superficial and mid dermal partial thickness burns: Evidence for the '12-hour rule'.
Harish V; Li Z; Maitz PKM
Burns; 2019 Jun; 45(4):936-941. PubMed ID: 30553529
[TBL] [Abstract][Full Text] [Related]
47. Split thickness skin graft versus application of the temporary skin substitute suprathel in the treatment of deep dermal hand burns: a retrospective cohort study of scar elasticity and perfusion.
Galati V; Vonthein R; Stang F; Mailaender P; Kisch T
Int J Burns Trauma; 2021; 11(4):312-320. PubMed ID: 34557334
[TBL] [Abstract][Full Text] [Related]
48. Burn scar outcome at six and 12 months after injury in children with partial thickness scalds: Effects of dressing treatment.
Karlsson M; Steinvall I; Sjöberg F; Olofsson P; Elmasry M
Burns; 2020 May; 46(3):546-551. PubMed ID: 32165027
[TBL] [Abstract][Full Text] [Related]
49. Meshed Biobrane: a dressing for difficult topography.
Phillips LG; Jarlsburg C; Mathoney K; Gracia W; Meltzer T; Smith DJ; Robson MC
J Burn Care Rehabil; 1990; 11(4):347-51. PubMed ID: 2401692
[TBL] [Abstract][Full Text] [Related]
50. A randomised clinical trial comparing a hydrocolloid-derived dressing and glycerol preserved allograft skin in the management of partial thickness burns.
Vloemans AF; Soesman AM; Suijker M; Kreis RW; Middelkoop E
Burns; 2003 Nov; 29(7):702-10. PubMed ID: 14556729
[TBL] [Abstract][Full Text] [Related]
51. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds.
Purdue GF; Hunt JL; Gillespie RW; Hansbrough JF; Dominic WJ; Robson MC; Smith DJ; MacMillan BG; Waymac JP; Herndon DN
J Trauma; 1987 Feb; 27(2):155-7. PubMed ID: 3546711
[TBL] [Abstract][Full Text] [Related]
52. Biosynthetic compound dressings--management of hand burns.
Smith DJ; McHugh TP; Phillips LG; Robson MC; Heggers JP
Burns Incl Therm Inj; 1988 Oct; 14(5):405-8. PubMed ID: 3147806
[TBL] [Abstract][Full Text] [Related]
53. The use of Biobrane
Rogers AD; Blackport E; Cartotto R
Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
[TBL] [Abstract][Full Text] [Related]
54. Pediatric considerations in the use of Biobrane in burn wound management.
Bishop JF
J Burn Care Rehabil; 1995; 16(3 Pt 1):331-3; discussion 333-4. PubMed ID: 7673319
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of commonly used temporary skin dressings and a newly developed collagen matrix for treatment of superficial wounds.
Held M; Rothenberger J; Engelke AS; Tolzmann DS; Esfahani BJ; Schaller HE; Rahmanian-Schwarz A
Adv Skin Wound Care; 2015 Dec; 28(12):551-4. PubMed ID: 26562201
[TBL] [Abstract][Full Text] [Related]
56. The use of a polylactide-based copolymer as a temporary skin substitute in deep dermal burns: 1-year follow-up results of a prospective clinical noninferiority trial.
Selig HF; Keck M; Lumenta DB; Mittlböck M; Kamolz LP
Wound Repair Regen; 2013; 21(3):402-9. PubMed ID: 23627672
[TBL] [Abstract][Full Text] [Related]
57. Clinical experience with Biobrane biosynthetic dressing in the treatment of partial thickness burns.
Hansbrough JF; Zapata-Sirvent R; Carroll WJ; Dominic WJ; Wang XW; Wakimoto A
Burns Incl Therm Inj; 1984 Aug; 10(6):415-9. PubMed ID: 6478287
[TBL] [Abstract][Full Text] [Related]
58. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
Tanaka M; Nakakita N; Kuroyanagi Y
J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
[TBL] [Abstract][Full Text] [Related]
59. The application of new biosynthetic artificial skin for long-term temporary wound coverage.
Wang HJ; Chou TD; Tsou TL; Chen TM; Chen SL; Chen SG; Wei LG; Yeh KJ; Ko YH; Wang CS; Lee WH
Burns; 2005 Dec; 31(8):991-7. PubMed ID: 16274930
[TBL] [Abstract][Full Text] [Related]
60. A Quantitative Analysis of Microcirculation in Skin Defects Covered with Topical Wound Dressings or a Newly Developed Collagen Matrix.
Held M; Medved F; Petersen W; Tolzmann DS; Rahmanian-Schwarz A; Schaller HE; Rothenberger J
Adv Skin Wound Care; 2017 Nov; 30(11):517-521. PubMed ID: 29049260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
